Wald Arnold
Dr Wald is a professor of medicine in the Division of Gastroenterology and Hepatology at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin.
Gastroenterol Hepatol (N Y). 2016 Mar;12(3):155-64.
Many patients with fecal incontinence respond to conservative measures based upon a careful assessment and a multimodality approach that Is within the expertise of the practicing gastroenterologist. However, there Is a need for new and effective strategies when conservative therapy fails. This article reviews established therapies for fecal incontinence, such as biofeedback, as well as new therapies that have been approved by the US Food and Drug Administration (FDA), such as sacral neuromodulation and an injectable bulking agent. Also reviewed are some of the newer approaches that have not yet been approved by the FDA or that have uncertain efficacy.
许多大便失禁患者对基于仔细评估和多模式方法的保守措施有反应,这些措施属于执业胃肠病学家的专业范畴。然而,当保守治疗失败时,就需要新的有效策略。本文回顾了已确立的大便失禁治疗方法,如生物反馈疗法,以及已获美国食品药品监督管理局(FDA)批准的新疗法,如骶神经调节和可注射填充剂。还回顾了一些尚未获FDA批准或疗效不确定的较新方法。